Inflammatory Response Research Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$150K
Inflammatory Response Research General Information
Description
Developer of drugs intended for inflammatory disorders. The company focuses on pharmaceutical products for the treatment of inflammatory disorders and conditions and its products are the oral combination of levocetirizine and montelukast for the treatment of influenza, enabling patients to recover inflammatory disorders.
Contact Information
Website
www.irrinc.netCorporate Office
- 515 East Micheltorena
- Suite G
- Santa Barbara, CA 93103
- United States
Corporate Office
- 515 East Micheltorena
- Suite G
- Santa Barbara, CA 93103
- United States
Inflammatory Response Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 18-Dec-2018 | $150K | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 20-Nov-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 04-Oct-2016 | $15K | $875K | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 02-Dec-2014 | $860K | $860K | Completed | Generating Revenue |
Inflammatory Response Research Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Inflammatory Response Research Patents
Inflammatory Response Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180169091-A1 | Levocetirizine and montelukast in the treatment of inflammation mediated conditions | Active | 15-Sep-2014 | ||
| US-9925183-B2 | Levocetirizine and montelukast in the treatment of inflammation mediated conditions | Active | 15-Sep-2014 | ||
| US-20170173001-A1 | Levocetirizine and montelukast in the treatment of inflammation mediated conditions | Active | 15-Sep-2014 | ||
| EP-3193875-B1 | Levocetirizine and montelukast in the treatment of inflammation mediated conditions | Active | 15-Sep-2014 | ||
| EP-3193875-A1 | Levocetirizine and montelukast in the treatment of inflammation mediated conditions | Active | 15-Sep-2014 | A61K31/495 |
Inflammatory Response Research FAQs
-
When was Inflammatory Response Research founded?
Inflammatory Response Research was founded in 2011.
-
Where is Inflammatory Response Research headquartered?
Inflammatory Response Research is headquartered in Santa Barbara, CA.
-
What industry is Inflammatory Response Research in?
Inflammatory Response Research’s primary industry is Pharmaceuticals.
-
Is Inflammatory Response Research a private or public company?
Inflammatory Response Research is a Private company.
-
What is Inflammatory Response Research’s current revenue?
The current revenue for Inflammatory Response Research is .
-
How much funding has Inflammatory Response Research raised over time?
Inflammatory Response Research has raised $2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
